Edwards Lifesciences (NYSE:EW) Vs. ABT, MDT, ISRG, SYK, BDX, BSX, DXCM, IDXX, BAX, and RMD
Should you be buying Edwards Lifesciences stock or one of its competitors? The main competitors of Edwards Lifesciences include Abbott Laboratories (ABT), Medtronic (MDT), Intuitive Surgical (ISRG), Stryker (SYK), Becton, Dickinson and (BDX), Boston Scientific (BSX), DexCom (DXCM), IDEXX Laboratories (IDXX), Baxter International (BAX), and ResMed (RMD). These companies are all part of the "health care equipment" industry.
Edwards Lifesciences vs.
Medtronic (NYSE:MDT) and Edwards Lifesciences (NYSE:EW) are both large-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, valuation, media sentiment, analyst recommendations, community ranking, institutional ownership, profitability and earnings.
Medtronic has higher revenue and earnings than Edwards Lifesciences. Medtronic is trading at a lower price-to-earnings ratio than Edwards Lifesciences, indicating that it is currently the more affordable of the two stocks.
79.6% of Medtronic shares are held by institutional investors. Comparatively, 80.6% of Edwards Lifesciences shares are held by institutional investors. 0.5% of Medtronic shares are held by insiders. Comparatively, 1.4% of Edwards Lifesciences shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Medtronic currently has a consensus target price of $144.21, suggesting a potential upside of 34.94%. Edwards Lifesciences has a consensus target price of $120.00, suggesting a potential upside of 10.62%. Given Medtronic's stronger consensus rating and higher possible upside, research analysts plainly believe Medtronic is more favorable than Edwards Lifesciences.
Medtronic has a beta of 0.8, indicating that its stock price is 20% less volatile than the S&P 500. Comparatively, Edwards Lifesciences has a beta of 1.06, indicating that its stock price is 6% more volatile than the S&P 500.
In the previous week, Medtronic had 19 more articles in the media than Edwards Lifesciences. MarketBeat recorded 26 mentions for Medtronic and 7 mentions for Edwards Lifesciences. Edwards Lifesciences' average media sentiment score of 0.24 beat Medtronic's score of -0.02 indicating that Edwards Lifesciences is being referred to more favorably in the news media.
Medtronic received 317 more outperform votes than Edwards Lifesciences when rated by MarketBeat users. Likewise, 79.20% of users gave Medtronic an outperform vote while only 74.35% of users gave Edwards Lifesciences an outperform vote.
Edwards Lifesciences has a net margin of 29.00% compared to Medtronic's net margin of 14.80%. Edwards Lifesciences' return on equity of 28.13% beat Medtronic's return on equity.
Summary
Medtronic and Edwards Lifesciences tied by winning 9 of the 18 factors compared between the two stocks.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding EW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment >-1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Edwards Lifesciences (NYSE:EW) vs. Its Competitors
Edwards Lifesciences Competitors List
